Cencora demonstrated a strong start to fiscal 2025, with double-digit revenue and EPS growth driven by its U.S. healthcare solutions segment and strategic expansion in specialty services through ...

Cencora enjoyed robust double-digit growth over the last two years thanks ... assessments of the firm's financial health, investment strategy and efficacy (organic and inorganic), and shareholder ...

Full Year Revenue Growth Guidance: 8% to 10% ... aligning with its digital transformation strategy. Cencora Inc (NYSE:COR) is focusing on a customer-centric approach, collaborating with customers ...

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. AXP, COR and ...

John Arena, interim president of global pharma services at Cencora, discusses the importance of engaging with partners as ...

In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive $300 million from an early settlement of some prepaid shares of Cencora along ...

Growth at a reasonable price, or GARP, is an excellent strategy to earn quick investment profits. The GARP approach helps identify stocks priced below the market or any suitable target determined by a ...